Global Aptamers Market to Reach USD 4.38 Billion by 2031 Amid Diagnostic and Therapeutic Innovation

[San Diego, 4th June 2025] – Clearview Market Insights (CVMI) projects that the global aptamers market will grow from USD 1.52 billion in 2024 to USD 4.38 billion by 2031, achieving a compound annual growth rate (CAGR) of 16.3 percent. This strong outlook is supported by accelerating adoption in diagnostics, the rise of nucleic-acid therapeutics, and technological breakthroughs in aptamer discovery and modification.

"Aptamers offer a next-generation alternative to antibodies across diagnostics, therapeutics, and biosensors,” said Dr. Nicole Haider, senior molecular biology analyst at CVMI. “With AI-driven SELEX, nanotechnology convergence, and biosafety-grade modifications, aptamers are stepping into the biotech mainstream."

Request Sample @ https://clearviewmarketinsights.com/report-details/global-aptamers-market/

Key Numbers

  • 2024 Market Value: USD 1.52 billion
  • 2031 Market Value: USD 4.38 billion
  • Seven-Year CAGR: 16.3 percent
  • DNA Aptamers Share (2024): 48%
  • North America Market Share: 44%

Market Drivers

  • Oncology and infectious disease diagnostics
  • Chemical versatility and low immunogenicity
  • Growth in AI and high-throughput aptamer screening
  • Strong research pipelines in targeted delivery and biosensors

Company Highlights

  • SomaLogic expanded proteomic applications to over 7,000 protein targets.
  • Base Pair Biotechnologies launched AI discovery tools for aptamer affinity profiling.
  • Aptamer Group formed alliances with cell therapy developers.
  • NeoVentures deployed aptamer-based rapid test kits in food safety and agriculture.

Regional Insights

  • North America: Leads in therapeutic R&D and diagnostics adoption.
  • Asia-Pacific: Fastest-growing region with rising investment in precision medicine.
  • Europe: Focused on academic collaborations and diagnostic biosensor validation.
  • LATAM & MEA: Opportunities emerging in food safety and portable diagnostics.

2024–2025 Milestones

Quarter

Event

Outcome

Q1 2024

Base Pair debuts AI SELEX tool

Shortens lead identification by 35%

Q2 2024

WHO trials aptamer diagnostics for dengue

Positive early results in 3 countries

Q3 2024

SomaLogic expands SOMAscan diagnostic use

Validated for cardiac biomarkers

Q1 2025

Aptamer Group signs CAR-T targeting partnership

Therapeutic aptamer market entry confirmed

 

 

 

 

For more insights, visit https://clearviewmarketinsights.com/

 

About Clearview Market Insights:

Clearview Market Insights is a leading market research and consulting firm providing in-depth industry analysis and strategic recommendations for businesses worldwide.

 

Media contact:

Bhavani K

Marketing and Sales Head

ClearView Market Insights

Mail: sales@clearviewmarketinsights.com

Phone: +1 917-993-7369

447
Спонсоры
Поиск
Спонсоры
Спонсоры
Suggestions

Другое
Pine Derived Chemicals Market Opportunities, Business Forecast 2031
The Pine Derived Chemicals Market research report highlights market research and industry...
От sai_teja_123 14
Education
Peace Within: Soothing Guided Meditation for Healing Depression
Softening Sadness with Stillness and Self-Love. IntroductionIn today’s fast-paced,...
От shivani2307 41
Другое
What Will Make Gasbro138 the Most Reliable Online Slots Site in 2025?
Gasbro138 has quickly become one of the most popular and trusted online slot sites for players in...
От william43 846
Home & Garden
Why Deep Cleaning Your Home Makes a Big Difference
Keeping a home clean is essential for a healthy and comfortable lifestyle. Daily cleaning helps...
От maxkingson 925
Software
Affordable MS Office 365 Plans for Saudi Businesses
Looking for cost-effective productivity tools? VRS Technologies offers Affordable MS Office 365...
От vrstech123 239
Спонсоры
Спонсоры